Literature DB >> 17631072

Utility of cardiovascular magnetic resonance to predict left ventricular recovery after primary percutaneous coronary intervention for patients presenting with acute ST-segment elevation myocardial infarction.

Michael D Shapiro1, Koen Nieman, Khurram Nasir, Cesar H Nomura, Ammar Sarwar, Maros Ferencik, Suhny Abbara, Udo Hoffmann, Udo Hoffman, Herman K Gold, Ik-Kyung Jang, Thomas J Brady, Ricardo C Cury.   

Abstract

Cardiac magnetic resonance (CMR) has been shown to predict left ventricular (LV) recovery in patients after acute ST-segment elevation myocardial infarction. The purpose of this investigation was to determine the relative values of infarct transmurality and microvascular obstruction (MVO) using delayed enhancement CMR to predict LV recovery. We studied 17 patients (mean age 60 +/- 10 years, 14 men) presenting with first acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention who underwent CMR within 6 days after presentation and again at 6 months. In total 680 myocardial segments were evaluated, of which 267 (39%) demonstrated delayed hyperenhancement (DHE) and 116 (18%) demonstrated MVO. Unadjusted odds ratio (OR) for any improvement in regional LV function with increasing DHE category (<50%, 51% to 75%, >75% transmurality) was 0.20 (95% confidence interval [CI] 0.13 to 0.30, p <0.0001), whereas it was 0.40 (95% CO 0.28 to 0.55, p <0.0001) with increasing MVO category (0, <50th, >50th percentile). However, when coadjusted together, the relation remained robust with regard to degree of transmurality of DHE (OR 0.21, 95% CI 0.13 to 0.36, p <0.0001), but the relation was lost for MVO (OR 0.90, 95% CI 0.58 to 1.40, p = 0.64). In conclusion, when using the delayed enhancement technique for assessment of DHE and MVO, degree of infarct transmurality appears to be a more powerful predictor of LV recovery by CMR.

Entities:  

Mesh:

Year:  2007        PMID: 17631072     DOI: 10.1016/j.amjcard.2007.02.079

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging.

Authors:  Sebastiaan C A M Bekkers; Martijn W Smulders; Valéria Lima Passos; Tim Leiner; Johannes Waltenberger; Anton P M Gorgels; Simon Schalla
Journal:  Eur Radiol       Date:  2010-06-26       Impact factor: 5.315

Review 2.  Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis.

Authors:  Yasmin S Hamirani; Andrew Wong; Christopher M Kramer; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2014-09

Review 3.  Contrast-enhanced magnetic resonance imaging in the assessment of myocardial infarction and viability.

Authors:  Antti Saraste; Stephan Nekolla; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

4.  Comparison of long and short axis quantification of left ventricular volume parameters by cardiovascular magnetic resonance, with ex-vivo validation.

Authors:  Helene Childs; Lucia Ma; Michael Ma; James Clarke; Myra Cocker; Jordin Green; Oliver Strohm; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2011-08-11       Impact factor: 5.364

5.  Myocardial Extracellular Volume Estimation by CMR Predicts Functional Recovery Following Acute MI.

Authors:  Ananth Kidambi; Manish Motwani; Akhlaque Uddin; David P Ripley; Adam K McDiarmid; Peter P Swoboda; David A Broadbent; Tarique Al Musa; Bara Erhayiem; Joshua Leader; Pierre Croisille; Patrick Clarysse; John P Greenwood; Sven Plein
Journal:  JACC Cardiovasc Imaging       Date:  2016-10-19

Review 6.  Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction.

Authors:  Jamal N Khan; Gerry P McCann
Journal:  World J Cardiol       Date:  2017-02-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.